search results for

refine results

sort by

Date
Relevance

result type

Articles
Video

Wires
Press Releases

PBM trade group: Blaming payers for price hikes is red herring

CNBC's Meg Tirrell reports on the Pharmaceutical Care Management Association's response to Mylan blaming "the middlemen" for its EpiPen price hike.

Source: CNBC.com

Sen. Grassley: Need more transparency in drug pricing

Sen. Charles Grassley (R-Iowa), reacts to what Mylan CEO Heather Bresch had to say about the EpiPen pricing outrage.

Source: CNBC.com

Sen. Grassley: I want a written response from Mylan

Sen. Charles Grassley (R-Iowa), reacts to what Mylan CEO Heather Bresch had to say about the EpiPen pricing outrage.

Source: CNBC.com

Welch: Bresch should have apologized

Suzy Welch, LinkedIn contributing editor, discusses Mylan CEO Heather Bresch and what she had to say about the controversy surrounding Mylan's pricing of the EpiPen.

Source: CNBC.com

Mylan CEO: I've reached out to lawmakers

Heather Bresch, Mylan CEO, says lawmakers have not called her back after she reached out to members of Congress. We are doing everything we can to ensure no one goes without an EpiPen, says Bresch.

Source: CNBC.com

$300B pharma fight is real says Mylan's Bresch

Heather Bresch, Mylan CEO, says the fight is on to fix the health care system and she is willing to work with Congress to make it happen.

Source: CNBC.com

Mylan CEO: System incentivizes higher prices

Heather Bresch, Mylan CEO, says the health care system is broken and if you don't play in the system your products won't get to patients.

Source: CNBC.com

Mylan CEO: We fight every day for affordable medicine

Heather Bresch, Mylan CEO, urges changes to update the U.S. health care system and talks about the need to bring down drug costs. Patients are paying twice, says Bresch.

Source: CNBC.com

Mylan's perverse choice was to go around the system: CEO

Heather Bresch, Mylan CEO, discusses the need to update the U.S. health care system, and the company's plan to provide an alternate route on pricing.

Source: CNBC.com

Mylan CEO: Here’s why it costs $600 to buy an EpiPen

Heather Bresch, Mylan CEO breaks down the pricing path of the EpiPen and the company's plan to expand access to the drug.

Source: CNBC.com